thalidomide has been researched along with Sunburn in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Sunburn: An injury to the skin causing erythema, tenderness, and sometimes blistering and resulting from excessive exposure to the sun. The reaction is produced by the ultraviolet radiation in sunlight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thalidomide treatment had no significant effect on markers of apoptosis including sunburn cell formation and terminal deoxynucleotidyl transferase-mediated biotinylated deoxyuridine triphosphate nick end labelling, which identifies single-strand breaks in DNA." | 5.32 | Photoprotection by thalidomide in patients with chronic cutaneous and systemic lupus erythematosus: discordant effects on minimal erythema dose and sunburn cell formation. ( Cummins, DL; Gaspari, AA, 2004) |
| "Thalidomide treatment had no significant effect on markers of apoptosis including sunburn cell formation and terminal deoxynucleotidyl transferase-mediated biotinylated deoxyuridine triphosphate nick end labelling, which identifies single-strand breaks in DNA." | 1.32 | Photoprotection by thalidomide in patients with chronic cutaneous and systemic lupus erythematosus: discordant effects on minimal erythema dose and sunburn cell formation. ( Cummins, DL; Gaspari, AA, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cummins, DL | 1 |
| Gaspari, AA | 1 |
| Criado, PR | 1 |
| Vasconcellos, C | 1 |
| Omar, ED | 1 |
| Valente, NY | 1 |
| Sotto, MN | 1 |
| Martins, JE | 1 |
2 other studies available for thalidomide and Sunburn
| Article | Year |
|---|---|
Photoprotection by thalidomide in patients with chronic cutaneous and systemic lupus erythematosus: discordant effects on minimal erythema dose and sunburn cell formation.
Topics: Adult; Female; Humans; Immunosuppressive Agents; In Situ Nick-End Labeling; Lupus Erythematosus, Dis | 2004 |
Thalidomide inhibits human ultraviolet-B-induced skin inflammation?
Topics: Adult; Female; Humans; Immunosuppressive Agents; Male; Sunburn; Thalidomide; Treatment Outcome; Ultr | 2007 |